tissue factor-targeting monomethyl auristatin E antibody-drug conjugate (Nanolattix Biotechnology)

N/A

Report date: 2025/06/11 10:21:29

Base Information

Drug Nametissue factor-targeting monomethyl auristatin E antibody-drug conjugate (Nanolattix Biotechnology)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionTissue factor modulatorsTubulin depolymerization inhibitors

TargetsTissue factorTubulin

Therapy Area/IndicationsPancreatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNanolattix Biotechnology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesNanolattix Biotechnology Co Ltd

Inactive CompaniesN/A

Active IndicationsPancreatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A